Company intelligence / Profile preview

Tenaxis Medical

Mountain View, California, United Statesseamless.ai ↗

Ownership: Private
Development stage: Other

Overview

Tenaxis Medical developed a novel surgical sealant for mechanically sealing human tissue and artificial grafts. The product received FDA PMA approval as a vascular sealant in March 2013 and was also CE Marked for use across multiple surgical specialties. It had not been commercially launched in the US at the time of its acquisition by The Medicines Company on May 1, 2014. No additional clinical results are available post-acquisition.

Therapeutic areas: Men's HealthCardiovascularOther
Modalities: Device (Surgical sealant)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Tenaxis Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tenaxis Medical.

Explore the full profile